Cancer Survivors, Statin Use Among High Risk Survivors
Conditions
Keywords
Communication Tool, Cancer Survivors, Increase Statin, 16-1128
Brief summary
The purpose of this study is to collect initial data on what survivors of childhood, adolescent, and young adult cancer think of how information about statins is communicated. Statins are medications that lower cholesterol. The results of this study will be used to improve the communication about statins. This is to aid patients and their providers in making health care decisions together, also known as shared decision making.
Interventions
BEHAVIORALusual care
In order to characterize the content of and variation in usual care, the first 25 patients enrolled in the study will complete a post-visit questionnaire that asks what their doctor told them (if anything) about their risk of cardiovascular disease, risk reduction and statins specifically, and how this information was presented
BEHAVIORALstatin communication tool
The Statin Choice decision aid uses icon arrays to communicate the expected benefits of statins. This modified risk communication tool will maintain the components of the validated original. The adapted paper-based risk communication tool will describe modified risk profiles applicable to the survivors at increased risk for cardiac disease due to chest irradiation.
Sponsors
Memorial Sloan Kettering Cancer Center
Study design
Observational model
CASE_CONTROL
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
25 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* English speaking * A personal history of cancer, tumor, or a related illness * Followed in the Adult Long Term Follow Up Program * Received ≥ 2000 cGy radiation to the heart/chest * ≥Ten years post-radiation therapy to the heart/chest * Age ≥ 25 years old
Exclusion criteria
* Evidence of active progression of disease or recurrence * Neurocognitive deficits that impair ability to give informed consent * Current use of a statin * Diagnosis of another primary cancer for which the patient is currently undergoing radiation therapy chemotherapy, or bone marrow transplant * Diagnosis of CVD with or without current statin use
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| number of patients who initiated statins after the office visit | 1 year | This data will allow validation of the adapted tool in the cancer survivor population. Acceptability will be estimated using the tool describe which will be transformed to a 0 to 100 scale and summarized separately in the two populations using means and standard deviations.These preliminary statistics in both populations (intervention and usual care) will be utilized to design a future larger scale study powered to detect a difference between the two groups. |
Countries
United States
Outcome results
None listed